Inventor
COOK PHILLIP DAN
US164 patents
⚠️ This page may combine multiple inventors who share the name “COOK PHILLIP DAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ISIS PHARMACEUTICALS INC
47 patentsUSRE39464EJan 9, 2007
Oligonucleolotides having site specific chiral phosphorothioate internucleoside linkages
ISIS PHARMACEUTICALS INC235 citations99
US7105499B2Sep 12, 2006
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
ISIS PHARMACEUTICALS INC233 citations99
US7037646B1May 2, 2006
Amine-derivatized nucleosides and oligonucleosides
ISIS PHARMACEUTICALS INC197 citations99
US7015315B1Mar 21, 2006
Gapped oligonucleotides
ISIS PHARMACEUTICALS INC409 citations99
US6900297B1May 31, 2005
Amine-derivatized nucleosides and oligonucleosides
ISIS PHARMACEUTICALS INC187 citations99
US6783931B1Aug 31, 2004
Amine-derivatized nucleosides and oligonucleosides
ISIS PHARMACEUTICALS INC194 citations99
US6639062B2Oct 28, 2003
Aminooxy-modified nucleosidic compounds and oligomeric compounds prepared therefrom
ISIS PHARMACEUTICALS INC259 citations99
US6600032B1Jul 29, 2003
2′-O-aminoethyloxyethyl-modified oligonucleotides
ISIS PHARMACEUTICALS INC338 citations99
US6534639B1Mar 18, 2003
Guanidinium functionalized oligonucleotides and method/synthesis
ISIS PHARMACEUTICALS INC261 citations99
US6528631B1Mar 4, 2003
Oligonucleotide-folate conjugates
ISIS PHARMACEUTICALS INC461 citations99
US6451991B1Sep 17, 2002
Sugar-modified gapped oligonucleotides
ISIS PHARMACEUTICALS INC244 citations99
US6399754B1Jun 4, 2002
Sugar modified oligonucleotides
ISIS PHARMACEUTICALS INC121 citations99
US6395492B1May 28, 2002
Derivatized oligonucleotides having improved uptake and other properties
ISIS PHARMACEUTICALS INC234 citations99
US6335434B1Jan 1, 2002
Nucleosidic and non-nucleosidic folate conjugates
ISIS PHARMACEUTICALS INC558 citations99
US6326199B1Dec 4, 2001
Gapped 2′ modified oligonucleotides
ISIS PHARMACEUTICALS INC282 citations99
US6277603B1Aug 21, 2001
PNA-DNA-PNA chimeric macromolecules
ISIS PHARMACEUTICALS INC216 citations99
US6242589B1Jun 5, 2001
Phosphorothioate oligonucleotides having modified internucleoside linkages
ISIS PHARMACEUTICALS INC171 citations99
US6239265B1May 29, 2001
Oligonucleotides having chiral phosphorus linkages
ISIS PHARMACEUTICALS INC471 citations99
US6172209B1Jan 9, 2001
Aminooxy-modified oligonucleotides and methods for making same
ISIS PHARMACEUTICALS INC378 citations99
US6166199ADec 26, 2000
N-2 substituted purines
ISIS PHARMACEUTICALS INC157 citations99
US6153737ANov 28, 2000
Derivatized oligonucleotides having improved uptake and other properties
ISIS PHARMACEUTICALS INC460 citations99
US6127533AOct 3, 2000
2'-O-aminooxy-modified oligonucleotides
ISIS PHARMACEUTICALS INC227 citations99
US5914396AJun 22, 1999
2'-O-modified nucleosides and phosphoramidites
ISIS PHARMACEUTICALS INC169 citations99
US5808027ASep 15, 1998
N-2 substituted purines in oligonucleotides
ISIS PHARMACEUTICALS INC171 citations99
US5777092AJul 7, 1998
Heteroatomic oligonucleoside linkages
ISIS PHARMACEUTICALS INC128 citations99
US5700922ADec 23, 1997
PNA-DNA-PNA chimeric macromolecules
ISIS PHARMACEUTICALS INC810 citations99
US5688941ANov 18, 1997
Methods of making conjugated 4' desmethyl nucleoside analog compounds
ISIS PHARMACEUTICALS INC804 citations99
US5681941AOct 28, 1997
Substituted purines and oligonucleotide cross-linking
ISIS PHARMACEUTICALS INC1,392 citations99
US5677437AOct 14, 1997
Heteroatomic oligonucleoside linkages
ISIS PHARMACEUTICALS INC1,250 citations99
US5661134AAug 26, 1997
Oligonucleotides for modulating Ha-ras or Ki-ras having phosphorothioate linkages of high chiral purity
ISIS PHARMACEUTICALS INC249 citations99
US5623070AApr 22, 1997
Heteroatomic oligonucleoside linkages
ISIS PHARMACEUTICALS INC1,420 citations99
US5608046AMar 4, 1997
Conjugated 4'-desmethyl nucleoside analog compounds
ISIS PHARMACEUTICALS INC1,669 citations99
US5576208ANov 19, 1996
Antisense oligonucleotide inhibition of the RAS gene
ISIS PHARMACEUTICALS INC151 citations99
US5489677AFeb 6, 1996
Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms
ISIS PHARMACEUTICALS INC1,836 citations99
US5386023AJan 31, 1995
Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling
ISIS PHARMACEUTICALS INC1,009 citations99
US5378825AJan 3, 1995
Backbone modified oligonucleotide analogs
ISIS PHARMACEUTICALS INC1,016 citations99
US5223618AJun 29, 1993
4'-desmethyl nucleoside analog compounds
ISIS PHARMACEUTICALS INC578 citations99
US5218105AJun 8, 1993
Polyamine conjugated oligonucleotides
ISIS PHARMACEUTICALS INC1,173 citations99
US5138045AAug 11, 1992
Polyamine conjugated oligonucleotides
ISIS PHARMACEUTICALS INC1,414 citations99
US7202224B2Apr 10, 2007
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
ISIS PHARMACEUTICALS INC222 citations98
US7101993B1Sep 5, 2006
Oligonucleotides containing 2′-O-modified purines
ISIS PHARMACEUTICALS INC159 citations98
US6861514B2Mar 1, 2005
Nucleosidic and non-nucleosidic folate conjugates
ISIS PHARMACEUTICALS INC122 citations98
US6753423B1Jun 22, 2004
Compositions and methods for enhanced biostability and altered biodistribution of oligonucleotides in mammals
ISIS PHARMACEUTICALS INC88 citations98
US6747014B2Jun 8, 2004
Compositions and methods for non-parenteral delivery of oligonucleotides
ISIS PHARMACEUTICALS INC356 citations98
US6531584B1Mar 11, 2003
2'modified oligonucleotides
ISIS PHARMACEUTICALS INC407 citations98
US6440943B1Aug 27, 2002
Oligonucleotides having site specific chiral phosphorothioate internucleoside linkages
ISIS PHARMACEUTICALS INC80 citations98
US6222025B1Apr 24, 2001
Process for the synthesis of 2′-O-substituted pyrimidines and oligomeric compounds therefrom
ISIS PHARMACEUTICALS INC342 citations98
MERCK & CO INC
3 patentsUS7323449B2Jan 29, 2008
Thionucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
MERCK & CO INC58 citations98
US7125855B2Oct 24, 2006
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
MERCK & CO INC301 citations98
US6777395B2Aug 17, 2004
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus
MERCK & CO INC356 citations98
Showing the top 50 of 164 patents by PatentIndex Score.